MyoPax Denmark ApS: Financial statements 2024
CVR: 43078046
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
MyoPax Denmark ApS (CVR 43078046) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -1,196,109 and a net result of DKK -1,869,338 compared with DKK -5,320,286 the year before. Equity in the 2024 report amounted to DKK -9,137,485. The company had 1 employee in the financial year.
- Gross Profit
- DKK -1,196,109
- Profit/Loss
- DKK -1,869,338
- Equity
- DKK -9,137,485
- Total Assets
- DKK 1,888,465
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -1.2M | -1.9M | -9.1M | 1 |
| 2023 | - | -4.9M | -5.3M | -7.3M | 2 |
| 2022 | - | -1.8M | -2M | -1.9M | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
MyoPax Denmark ApS has published its annual report for 2023. Gross profit came to DKK -4,852,720, and the net result was DKK -5,320,286.
About MyoPax Denmark ApS
MyoPax Denmark ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2022. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named KR 1974 ApS. The management consists of Verena Jennifer Johanna Schöwel-Wolf. The board consists of Simone Spuler and Verena Jennifer Johanna Schöwel-Wolf. The company is owned by MyoPax GmbH. The company has 1 employee (2024). In 2025, the company reported a gross profit of DKK -286,390 and a net result of DKK -833,247 compared with DKK -1,869,338 the year before. Equity in the 2025 report amounted to DKK -9,970,731.